REN and hydrops fetalis: We show that targeted suppression with DRI-aliskiren, initiated at Stage B HF, reduces elevated plasma renin activity concentration to normal levels and decreased plasma neprilysin levels, without affecting the plasma levels of Ang II and aldosterone.